[1]
E. Zafiriou, E. Karampinis, V. . Papadopoulos, G. . Stefani, A. . Kotsakis, and G. . Vassilopoulos, “Non-Melanoma Skin Cancer Aggravation in Polycythemia Vera: Triggered by Ruxolitinib and Silenced With an IFN/Cemiplimab”, Dermatol Pract Concept, vol. 15, no. 1, p. 4642, Jan. 2025, doi: 10.5826/dpc.1501a4642.